SETONDA is a dynamically developing pharmaceutical company established in November 2012 within the GMG Group to research, develop and produce high quality innovative pharmaceutical products with patient focus to reach end users and health care providers all over Europe. SETONDA specializes in the research, development, production processes and market access of modern, innovative products and value-added generics based on organic, synthetic and herbal compounds. GMG Group aims to further specialize in intra-group product research and development processes, by consolidating all R&D activities in Spain under SETONDA SETONDA has also established strategic collaborations and cooperation with many international pharmaceutical companies at all pre-production stages such as product development, clinical and preclinical studies, laboratory testing, and preparation processes for GMP audit inspections by EU health authorities.